丸善雄松堂株式会社
学術情報ソリューション事業部
法律情報営業部

〒160-0002
東京都新宿区四谷坂町10-10
Tel: 03-3357-1435
Fax: 03-3357-2805

※おしらせ※
2018年5月7日(月)より
電話・Fax番号が変わります。
新番号 Tel: 03-6367-6120
    Fax: 03-6367-6215

ご注文に際して

個人情報保護方針

コーポレートサイト

米国医療法律家協会編:臨床研究実務ガイド 第2版

Clinical Research Practice Guide, 2nd Edition

R. Harold McCard (Editor)

1 vol. xiv, 197pp. Paperbound with CD-Rom. 2013.

American Health Lawyers Association (AHLA). ISBN: 9780769860961

¥29,784

在庫あり

臨床研究の被験者保護、製薬・医療機器・生物製剤における同意手続、新薬臨床試験開始届、新薬申請書、簡略化新薬申請に関するガイド。米国知的財産権の基礎から、特許出願、侵害の申立てなどについても、チェックリストやサンプル書式を交え解説。

【Table of Contents】

1 Protection of Human Research Subjects; Melissa L. Markey

1.1 Protection of Human Subjects

1.2 Background of Human Subject Protection and Sources of Ethical Guidance

1.3 Informed Consent and Research

Conclusion

2 Institutional Review Boards: Ensuring the Protection of Human Research Participants; Melissa L. Markey

2.1 The Development of Human Subject Protection in the United States

2.2 Federal Regulation of Research

2.3 Applicability of Federal IRB Regulations

2.4 Composition of the IRB

2.5 The IRB Review Process

2.6 Vulnerable Populations

2.7 Conclusion

3 A Brief Overview of the Federal Regulatory Approval Process for Pharmaceuticals, Biologics, Medical Devices, and Combination Products; David S. Weinstock and Jamie K. Wolszon

3.1 Introduction

3.2 FDA's Role

3.3 The Human Drug Development Process

3.4 Investigational New Drug Application (IND)

3.5 Stages of a Clinical Trial

3.6 New Drug Application (NDA)

3.7 Abbreviated New Drug Application (ANDA)

3.8 Regulatory Process Relating to Biologics

3.9 Regulation of Medical Devices

3.10 Combination Products

Exhibit A--Drug Review Steps

Exhibit B--Select Glossary/Common Abbreviations

Exhibit C--Useful Citations and Resources

4 Regulatory Oversight and Investigations; David S. Weinstock

4.1 FDA

4.2 Office for Human Research Protections

4.3 Office of Research Integrity

4.4 National Institutes of Health

4.5 Office of Inspector General

5 An Overview of Intellectual Property for the Healthcare Law Practitioner; Jonathan Holda, E. Scott Johnson, and Christopher F. Lonegro

5.1 Basis of U.S. Intellectual Property Rights

5.2 What is a Patent?

5.3 What is a Trademark?

5.4 What is a Copyright?

5.5 Privacy Policy

5.6 What is a Trade Secret?

5.7 Sample Relevant Legal Developments

Addendum A--Overview of the Patent Application Process

Exhibit A--Patent Claims: A Primer

Addendum B--Sample Patent Claims

Addendum C--Dealing with Allegations of Patent Infringement

Addendum D--Dos and Don'ts of Laboratory Notebooks

Exhibit B--Institutional Intellectual Property (IP) Checklist and Sample IP Clauses

6 HIPAA, HITECH and Information Management in Clinical Research; Sarah E. Swank and Aaron J. Rabinowitz

6.1 Introduction

6.2 Federal Laws Governing Information Protection and Management

6.3 Other Legal Considerations

6.4 Conclusion

7 Insurance Coverage for Clinical Trial Services; Lawrence W. Vernaglia, Leeann M. Habte, Monica R. Chmielewski, and Torrey K. Young

7.1 General Concepts and Funding for Clinical Trials

7.2 Medicare Coverage for Clinical Trials

7.3 Specific Criteria for Medicare Coverage of Clinical Trials

7.4 Medicare Coverage for Medical Device Trials

7.5 Medicaid and Commercial Insurance Coverage for Clinical Trials

7.6 Ten Steps to Successful Billing

7.7 Enforcement Activities

7.8 Landmark Case--The Rush Settlement

Index